The glycoprotein P0, the major structural protein of the peripheral nerve myelin, plays a critical role in holding myelin lamellae together via interaction of both extracellular and cytoplasmic domains. Mutations in the human P0 gene give rise to severe and progressive forms of dominantly inherited peripheral neuropathies like CMT1B. Here we report on the characterization of a bovine P0-derived protein of nearly 26 kD that corresponds to the P0 protein truncated in its cytoplasmic domain. Matrix assisted laser desorption ionization (MALDI)-time-of-flight/time-of-flight (TOF/TOF) mass spectrometry (MS) analysis on its tryptic digest has provided a peptide mapping, the main difference of which from the normal It has been recently shown that coexpression of wild type and cytoplasmically truncated P0 causes loss of wild-type function, presumably attributable to a dominant negative effect of the truncated molecule [6] , and it has been demonstrated that the deletion of a 14 amino acid sequence in the cytoplasmic domain of P0 abolishes its adhesive function [7] .
P 0 is a 30 kDa glycoprotein of the peripheral nerve myelin involved in normal myelin organization and function [1] . The occurrence of some peripheral neuropathies, in mice, has been associated to absence or overexpression of P0 [2] . In addition, mutations in the human P0 gene cause the inherited demyelinating peripheral neuropathy Charcot-Marie-Tooth disease type 1B (CMT1B) [3] , the Dejerine-Sottas syndrome [4] (DSS), and congenital hypomyelination (CH) [5] .
It has been recently shown that coexpression of wild type and cytoplasmically truncated P0 causes loss of wild-type function, presumably attributable to a dominant negative effect of the truncated molecule [6] , and it has been demonstrated that the deletion of a 14 amino acid sequence in the cytoplasmic domain of P0 abolishes its adhesive function [7] .
As a part of our ongoing project on the proteomics of the peripheral nerves [8 -10] ,°we°have°isolated°by SDS-PAGE a low-molecular weight P0-related protein from bovine sciatic nerve. A previous report has already described the presence of a lower molecular weight P0-like protein in peripheral nerve myelin from rat. The latter, according to the authors, originated during the incubation at 37°C of nerve slice preparations and of crude myelin incubation by a cleavage caused by a not well defined protease that might°be°present°in°the°myelin° [11] .°The°mass°spec-trometry/mass spectrometry (MS/MS) approach exploited in the structure elucidation of the proteins separated by 1-D gel allows overcoming drawbacks that may arise from protein overlapping in the electrophoretic separation.
Experimental

Protein Extract Preparation
Bovine sciatic nerve, obtained from the local slaughterhouse within one hour of the animal's slaughter, was cut into pieces of nearly 1 cm long. These were snap frozen in liquid nitrogen and immediately transported to the laboratory and stored frozen at Ϫ80°C until use. A portion of the frozen nerve (20 -30 mg wet) was thawed and washed in buffer (0.32 M Sucrose, 20 mM Tris pH 7.5, 1 mM EDTA, 1 M leupeptin, 1 M aprotinin, 0.2 mM PMSF, 2 mM sodium orthovanadate) at 4°C, rinsed with nondenaturing lysis buffer (10 mM Tris pH 7.4, 1 mM EDTA, 1 M leupeptin, 1 M aprotinin, 0.2 mM PMSF, 2 mM sodium-orthovanadate), and directly sonicated by an Ikasonic U50 sonicator (Ikalabortechnik, Staufen, Germany) at the highest setting for 3 cycles of 20 s, in 500 l of denaturing lysis buffer (2.5% SDS, 62.5 mM Tris-HCl pH 6.8, 1 mM EDTA, 0.2 M PMSF, 10% glycerol, 1 M aprotinin, 1 M leupeptin). The homogenate was then centrifuged at 13,000 RPM for 10 min in a micro-centrifuge, and the supernatant was collected. The protein concentration in the extract was determined by a DC protein kit assay (Bio-Rad Laboratories, Hercules, CA) using BSA as a standard.
Monodimensional SDS-Polyacrylamide Gel Electrophoresis (PAGE)
Samples in lysis buffer were loaded onto gel without boiling and reducing agents (15 g per lane). A minigel°system°of°Laemmli° [12] °was°utilized,°consist-ing of a 15% homogeneous polyacrylamide resolving gel. The current was set at 25 mA and the migration was stopped when the tracking dye reached the down limit of the gel (nearly two h). The gel was than subjected to standard Coomassie blue staining.
Protein In-Gel Digestion
The Coomassie blue stained protein bands of interest were excised from the gel using a razor blade. A blank control was obtained using a piece of gel cut in a blank region of the gel and processed in parallel with the sample bands. The gel slices were subjected to reduction by 10 mM DTT and alkylation by 55 mM iodoacetamide°before°trypsin°digestion° [13,°14] .°The gel slices were than washed with 50% acetonitrile/25 mM NH 4 CO 3 , dried under vacuum, and rehydrated in 25 mM NH 4 CO 3 containing trypsin (Promega, Madison, WI) 0.01 g/l. The mixture was left standing overnight at 37°C. Peptide were extracted by one change of water and two changes of 0.5% TFA/50% acetonitrile at room-temperature and dried down.
MALDI-TOF TOF MS/MS Peptide Sequence
Mass spectra were recorded on a 4700 Proteomics analyzer with TOF/TOF optics (Applied Biosystems, Foster City, CA). A 200-Hz frequency-tripled Nd:YAG laser was used.
An average of 5000 to 8000 laser shots were used to acquire the MS/MS spectra from ␣-CHCA matrix. The collisions were carried out using air as collision gas and by setting the collision energy at 1 KV, defined as the difference between the accelerating potential, fixed at 8 kV and the floating cell, kept at 7 kV. The internal calibration was performed by using five peptides in the range 900 -2500 u as standards.
MALDI spectra were elaborated by in-house software packages. MASCOT was used for database search. The search parameters used were peptide mass tolerance: 50 ppm; enzyme: trypsin (cuts C-term side of K and R unless next residue is P); variable modifications: Oxidation (M), Pyro-glu (N-term Q); 
Results and Discussion
The one-dimensional gel electrophoresis of the protein extract of bovine sciatic nerve displayed the known myelin proteins P0 and P2 as the most abundant bands (Figure°1).°Even°though°the°resolution°of°this°chromato-graphic separation is not appropriate for an accurate investigation of the other less abundant nerve proteins, nevertheless a band migrating faster than that of the P0 one, of ϳ26 kDa molecular weight, was clearly detected in the Coomassie stained gel. Mass spectrometry has been used extensively in neuroscience° [15] .°The°tryptic°digests°of°both°P0°and P0-LMW were submitted to MALDI analysis in a MALDI-TOF/TOF instrument, and the spectra thus obtained°are°displayed°in°Figure°2a°(P0)°and°2B°(P0-LMW). The expanded region above 1460 u highlights the missing sequences in the P0-LMW protein.
The main differences between the two spectra are attributable to the absence of the clusters centered around°m/z 1530°in°the°spectrum°of°Figure°2b.°More-over,°the°matching°of°ions°sets°present°in°both°Figure°2a and°b°with°the°MASCOT°database°leads°to°the°identi-fication of both proteins as the well-known P0, with a similar score. It can be assumed, therefore, that P0 and P0-LMW proteins are structurally similar. The mass fingerprint°of°the°spectrum°reported°in°Figure°2a,°used to identify the protein, leads to the recognition of several°sequence-specific°peptides°(Table°1). The two satellites peptides attributable to classic chemistry that the wild type sequence has gone through during sample preparation provide additional clues on the structure of the 186 -198 segment of the P0 protein sequence, the identification of which was based on the information input regarding the molecular weight and of the selected enzymatic procedure only.
An independent validation of a peptide primary structure is now offered by the TOF-TOF methodology that allows the use of the classic ion chemistry principles°to°establish°the°structure°of°unknowns° [16] . In particular, an indirect proof of the presence of Leucine (L) or Isoleucine (I) at the 5 and 9 positions of the°primary°structure°of°the°examined°peptide°(Table°1, entry°9)°would°be°important° [17] .
When the protonated peptide at m/z 1530.7701 is selected by the first TOF and allowed to react in the floating cell with inert gas (see the Experimental section),°the°MS/MS°spectrum°reported°in°Figure°3°was obtained after ion analysis performed by the second TOF operated in the reflectron mode. The MS/MS spectrum provided the complete sequence of the peptide by the appearance of the appropriate y, b, and i ions (Scheme 1). Moreover, the presence of L residues was confirmed by the presence of the w i ions at m/z 1046.47 and 568.25.
The QTPVLYAMLDHSR corresponding to the 186 -198 sequence of the bovine P0 myelin was, therefore, confirmed. Similarly, it was confirmed for the structure of°the°modified°peptides°8 and°10 (Table°1).
The MS/MS experiments were also carried out on the°other°relevant°tryptic°peptides°2-4 and°7 (Table°2), the structures of which were easily confirmed by the appearance of the full y and b ion series.
A deeper evaluation of the available data were needed°to°validate°sequence°5 (Table°1).°Database search°of°the°spectrum°in°Figure°2a°identifies°this species, initially observed at m/z 1235.7169, as the segment 70 -79 of P0 myelin with very low mass accuracy, Ϫ42.10°ppm.°Its°MS/MS°spectrum°(Figure°4a)°was sufficiently informative; however, a relevant fragment at m/z 409.22 was not recognized.
The de novo-sequencing analysis, starting from m/z 392,°provided°four°other°sequences°(Table°3),°having°in common the last eight amino acid sequences that might fit the experimental data.
The discriminating parameter among the sequences 1-°4°(Table°3)°is°represented°by°the°mass°accuracy°only (Table°3,°third°column)°that°is°related°to°the°calibration initially used in the acquisition of spectrum 2A. The instrument was then recalibrated three times in the interval°1107°Ϭ°1353,°using°the°peptides°3 and°4 (Table  1) °as°internal°standards,°obtaining°an°average°value°of 1235.6643 u and the mass accuracies reported in the fourth°column°of°Table°3.°Peptides°5 (Table°1)°and°1 (Table°3)°are°isobaric,°therefore,°on°the°ground°of°the recalculated mass accuracy of 0.48 ppm only, both of them might correspond to the 70 -79 segment of P0.
As previously mentioned, the identification of 5 from mass peptide fingerprint left one mass fragment unassigned, whereas the de novo-sequencing analysis of 1 was not able to recognize the species at m/z 1107.68, if the species were considered to be the 70 -79 fragment of P0° (Figure°4b) . This is a particular case in which the databases or the fragmentation software cannot unambiguously recognize the structure of a peptide. It can be suggested, however, that the ionic species at m/z 409.92 could be due to a consecutive reaction path taken by the ion fragment at m/z 1107.68. Evidence is provided by the observation that the MS/MS spectrum of 1107.57 (entry 4,°Table°1)°gives°rise°to°the°fragment°at°m/z 409.22, which is in turn recognized either by the database or by the in silico fragmentation tool as a typical ion of that sequence°(Figure°4c).
It can be assumed, therefore, that the electrophoretic spot submitted to tryptic digestion corresponds to the well known P0 protein. Accordingly, the new P0-LMW myelin protein is of necessity strictly related to it. The QTPVLYAMLDHSR sequence is, therefore, unambiguously missed in the P0-LMW, and represents a good marker of the P0 cytoplasmic domain region. The presence of this truncated protein in samples obtained from fresh frozen nerve extracts and rigorously processed at low temperatures let us to exclude the possible involvement of an endogenous protease during the experimental manipulations, as suggested by Agrawal and°coworkers° [11] .°It°can°be°assumed,°therefore,°that this P0 derived protein is not an artifact but that it is usually present in the myelin membrane and that it might have a functional role in the myelin architecture.
Conclusions
We have been able to identify by SDS-PAGE and mass spectrometry a P0-like protein in the pool of myelin sheath proteins characterized by a molecular weight lower than that of P0 and lacking almost one peptide sequence among those already described in previous experiments°[8° -10] .
The specificity of tandem mass spectrometry, now available with MALDI ionization, provides the advantage of validating the peptide structure by means of classic gas-phase ion-chemistry tools applied to peptide enzymatic digest, thus offering an unique method to validate the database searching against mismatch that could arise from the fact that, in this case too, the peptide sequence is theoretically reconstructed from cDNA.
